agar
Agar, or agar-agar, is a jelly-like substance consisting of polysaccharides obtained from the cell walls of some species of red algae, primarily from the Gracilaria genus and the Gelidiaceae family (tengusa). As found in nature, agar is a mixture of two components, the linear polysaccharide agarose and a heterogeneous mixture of smaller molecules called agaropectin. It forms the supporting structure in the cell walls of certain species of algae and is released on boiling. These algae are known as agarophytes, belonging to the Rhodophyta phylum. The processing of food-grade agar removes the agaropectin, and the commercial product is essentially pure agarose. — Wikipedia
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Earliest trial started Nov 1, 2013 (NCT02012543)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaAgar ↗
- ChEMBLCHEMBL2108215 ↗
Also known as
- agar
- agar
- agar
- agar
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05234658 | Phase 2 | Jan 21, 2022 | Andalusian Network for Design and Translation of Advanced Therapies |
| NCT05024188 | N/A | Dec 1, 2021 | Hebrew University, Weizmann Institute of Science |
| NCT02012543 | N/A | Nov 1, 2013 | Showa Inan General Hospital |
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Andalusian Network for Design and Translation of Advanced Therapies | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Hebrew University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Showa Inan General Hospital | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Weizmann Institute of Science | Academic/Hospital | 1 | 0 | 1 | 2021 |